Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Speciality: Oncology


Speaker:

Dr Riyaz Ahmed | Director Hemato oncology

Dr Isha Kaul | Associate director Hematology

Dr Nitin Gupta | Sr.Consultant Clinical Hematology

Description:

Welcome to our special feature on relapsed B-cell Acute Lymphoblastic Leukemia (B-cell ALL) in adults. Join leading experts Dr. Riyaz Ahmad, Dr. Nitin Gupta, and Dr. Eesha Kaul as they explore the latest breakthroughs in treating this aggressive form of leukemia. With years of experience in hematology and oncology, they bring valuable insights into how modern medicine is reshaping the outlook for adult patients.

In this video, our experts discuss the challenges of relapsed B-cell ALL and how innovative treatments like CAR T-cell therapy, blinatumomab, and inotuzumab ozogamicin are offering new hope. They highlight the importance of precision medicine, the evolving role of stem cell transplantation, and the need for holistic care in improving outcomes and quality of life for patients.

Thank you for watching. We hope this video offers clarity and encouragement to patients, families, and healthcare professionals. Don’t forget to like, share, and follow our channel for more updates on cutting-edge treatments and expert perspectives in cancer care.

 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.

2.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

5.

A garden can save your life


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot